In the context of IBD-associated cancer, studies in the AOM/DSS mouse model have shown that ablation of CD4+Foxp3+ Treg cells suppressed tumor growth, which was associated with increased numbers of CD8+IFN-γ+ Granzyme B-producing effector T cells [162,163] (Table 1). This evidence concerns the gene CD4 and inflammatory bowel disease.